Abstract A62: A novel Eg5 inhibitor that causes mitotic arrest leading to rapid cancer cell death shows broad‐spectrum antitumor activity in preclinical xenograft tumor models

Author(s):  
Xiang S. Ye ◽  
Li Fan ◽  
Robert Van Horn ◽  
Tinggui Yin ◽  
Ryuichiro Nakai ◽  
...  
Cell Division ◽  
2019 ◽  
Vol 14 (1) ◽  
Author(s):  
Gianandrea Traversi ◽  
David Sasah Staid ◽  
Mario Fiore ◽  
Zulema Percario ◽  
Daniela Trisciuoglio ◽  
...  

2019 ◽  
Vol 55 (30) ◽  
pp. 4407-4410 ◽  
Author(s):  
Li Li ◽  
Yue Zhao ◽  
Ran Cao ◽  
Lin Li ◽  
Gaihong Cai ◽  
...  

Through ABPP, piperlongumine was identified to induce cancer cell death by covalently binding and inhibiting GSTO1 and has a broad spectrum synergistic effect with other anti-cancer agents.


2016 ◽  
Vol 23 (15) ◽  
pp. 1513-1527 ◽  
Author(s):  
Magdalena Gorska ◽  
Alicja Kuban-Jankowska ◽  
Jaroslaw Slawek ◽  
Michal Wozniak

2019 ◽  
Vol 234 (11) ◽  
pp. 20648-20661 ◽  
Author(s):  
Zhen Yu ◽  
Ze Yu ◽  
ZhenBao Chen ◽  
Lin Yang ◽  
MingJun Ma ◽  
...  

RSC Advances ◽  
2021 ◽  
Vol 11 (8) ◽  
pp. 4454-4464
Author(s):  
Nour E. A. Abd El-sattar ◽  
Eman H. K. Badawy ◽  
Eman Z. Elrazaz ◽  
Nasser S. M. Ismail

PARP-1 are involved in DNA repair damage and so PARP-1 inhibitors have been used as potentiators in combination with DNA damaging cytotoxic agents to compromise the cancer cell DNA repair mechanism, resulting in genomic dysfunction and cell death.


Sign in / Sign up

Export Citation Format

Share Document